European Journal of Organic Chemistry
10.1002/ejoc.201601650
COMMUNICATION
but some free amino acid was still present. To complete the Experimental Section
cyclization, the crude product was simply heated for 8 h in
pyridine, and thus the γ-spirolactam 1a was isolated in 98% after
one crystallization (entry 6). After the successful optimization of
the hydrogenation conditions, we repeated the reaction with 20
mmol of cyclohexadiene 3a and only 50 mg (1 mol%) of
platinum(IV) oxide, to demonstrate the applicability of the method
on larger scales. Indeed, the yield of lactam 1a was still
excellent (entry 7) and the product was isolated in analytical
pure form. Therefore, this method was employed as general
procedure for the cyclohexadienes 3b–d as well (Table 2,
Experimental Section, and Supporting Information).
General procedure for Birch reductions: Benzoic acid 2 (100 mmol)
was introduced into a three-necked flask (500 mL) equipped with a dry-
ice condenser and cooled to – 78 °C by a dry-ice acetone bath. Ammonia
(
200 mL) was condensed into the three-necked flask, and lithium (1.39 g,
00 mmol) was added in small pieces to the solution at – 78 °C, until it
remained blue. After stirring for 1 h at – 78 °C, chloroacetonitrile (10.0 mL,
60 mmol) was added via syringe within 2 min and the ammonia was
2
1
allowed to evaporate overnight at RT. The solid residue was dissolved in
water (70 mL), cooled to 0 °C, acidified with 6 M HCl to pH 2 and
extracted with dichloromethane (3 x 50 mL). The combined organic
layers were dried over sodium sulfate, filtered over a small pad of silica
gel, and the solvent was removed in vacuo. The crude products were
crystallized from n-hexane to obtain the cyclohexadienes 3 in analytically
pure form (Supporting Information).
In all hydrogenations, the double bonds and nitrile groups
were reduced in the same step, and the desired cyclohexane-
based γ-spirolactams 1 were obtained in very high yields (entries
7
–11). Interestingly, starting from the o- and m-isomers 2b and
c a new stereogenic center is formed during the hydrogenation
General procedure for catalytic hydrogenations: Cyclohexadiene 3
(20 mmol) was dissolved in methanol (300 mL) at RT and platinum(IV)
oxide (50 mg, 1 mol%) and 37% HCl (1.5 mL) was added. The solution
was purged with hydrogen gas for 5 min, equipped with a balloon filled
with hydrogen gas and hydrogenated under stirring for 48 h. The solution
was filtered through a pad of Celite, washed with methanol (2 x 50 mL),
and the solvent was removed in vacuo. The residue was dissolved in
pyridine (500 mL) and heated for 8 h under reflux. The pyridine was
removed in vacuo and the residue was dissolved in dichloromethane
2
with excellent selectivity. Thus, we could only isolate a single
diastereomer for both reactions (entries 8, 9). The relative
configurations were assigned unequivocally by X-ray analyses.
Since 1b and 1c crystallize in the centrosymmetric space group
P2
1
/c, the packing contains both enantiomers, only one of each
[
25]
is shown (Figure 3 and Supporting Information).
(
200 mL), extracted with 1 N HCl (100 mL), dried over sodium sulfate,
and concentrated in vacuo. The solid γ-spirolactams 1 crystallized from n-
hexane in analytically pure form (Supporting Information).
Acknowledgements
We thank the University of Potsdam for generous financial
support.
1
b
1c
Figure 3. Molecular structures of γ-spirolactams 1b and 1c.
Keywords: diastereoselectivity • hydrogenation • lactams •
reduction • synthetic methods
The methyl groups are oriented cis to the carbonyl groups
and thus the hydrogenation occurs from the opposite face. We
explain this high selectivity by a coordination of the nitrile, which
has to be reduced as well, to the metal surface during the
hydrogenation, in accordance to other heterogenic reactions of
[1]
Natural Lactones and Lactams: Synthesis, Occurrence and Biological
Activity (Ed.: T. Janecki), Wiley-VCH, Weinheim, 2013.
[
2]
Recent review: F. Rivas, T. Ling, Org. Prep. Proced. Int. 2016, 48, 254–
2
95.
[
[
3]
4]
Recent review: O. Nuyken, S. D. Pask, Polymers 2013, 5, 361–403.
Recent review: K. I. Molvi, N. Haque, B. Z. S. Awen, M. Zameeruddin,
World J. Pharm. Sci. 2014, 3, 536–563.
[
26]
this functional group.
Finally, since the p-isomers cis-2d and
trans-2d have been separated after the Birch reduction, we
obtained the corresponding diasteromerically pure γ-
spirolactams cis-1d and trans-1d as well (entries 10, 11).
[
5]
Reviews: a) R. Pradhan, M. Patra, A. K. Behera, B. K. Mishra, R. K.
Behera, Tetrahedron 2006, 62, 779–828; b) S. Kotha, A. C. Deb, K.
Lahiri, E. Manivannan, Synthesis 2009, 165–193. Very recent example:
X. Huang, M. Liu, K. Pham, X. Zhang, W.-B. Yi, J. P. Jasinski, W.
Zhang, J. Org. Chem. 2016, 81, 5362–5369.
In conclusion, we developed an easy entry to cyclohexane-
based γ-spirolactams in only two steps from benzoic acids. The
method is characterized by commercially available inexpensive
precursors. Birch reduction in the presence of chloroacetonitrile
on a large scale afforded cyclohexadienes in good to excellent
yields, isolated by simple crystallization. Subsequent
hydrogenation with platinum(IV) oxide as catalyst proceeded
smoothly, and the nitrile group and double bonds were reduced
in the same step with excellent stereoselectivities. After
cyclization, the γ-spirolactams were isolated in very high yields
by crystallization in analytically pure form. The relative
configurations have been established unequivocally by four X-
ray structures. Since various benzoic acids are commercially
available, the method might be applied for the synthesis of other
substituted γ-spirolactams, which are potential medicinal agents.
[6]
a) A. Wegert, B. Nolte, K. Linz, S. Harlfinger, B.-Y. Kögel, P. Ratcliffe, F.
Theil, O. Gröger, B. Braun, WO 2016/008583 A1, 2016; b) R.
Chesworth, L. H. Mitchell, J. E. Campbell, L. A. Reiter, K. K. Swinger,
WO 2016/044626 A1, 2016.
[
[
7]
8]
H. R. Kircheldorf, Makromol. Chem. 1975, 176, 57–79.
a) L. L. Winneroski, T. E. Mabry, N. J. Snyder, O. B. Wallace, Y. Xu,
WO 2007/127763, 2007; b) P. A. Reddy, B. C. H. Hsiang, T. N. Latifi, M.
W. Hill, K. E. Woodward, S. M. Rothman, J. A. Ferrendelli, D. F. Covey,
J. Med. Chem. 1996, 39, 1898–1906.
[9]
C. Hempel, N. M. Weckenmann, C. Maichle-Moessmer, B. J.
Nachtsheim, Org. Biomol. Chem. 2012, 10, 9325–9329.
[10] H.-R. Wu, L. Cheng, D.-L. Kong, H.-Y. Huang, C.-L. Gu, L. Liu, D.
Wang, C.-J. Li, Org. Lett. 2016, 18, 1382–1385.
[
[
11] T. Linker, T. Krüger, EP 2 554 539 B1, 2014.
12] Reviews: a) P. W. Rabideau, Tetrahedron 1989, 45, 1579–1603; b) P.
W. Rabideau, Z. Marcinow, Org. React. 1992, 42, 1–334; c) G. S. R.
Subba-Rao, Pure Appl. Chem. 2003, 75, 1443–1451.
This article is protected by copyright. All rights reserved.